Status of circulating bone turnover markers in elderly osteoporosis/osteopenia patients in comparison with healthy subjects

[1]Garnero P. The utility of biomarkers in osteoporosis management. Mol Diagn Ther. 2017; 21:401–18.GarneroPThe utility of biomarkers in osteoporosis managementMol Diagn Ther2017214011810.1007/s40291-017-0272-128271451Search in Google Scholar

[2]Srivastava AK, Vliet EL, Michael Lewiecki E, Maricic M, Abdelmalek A, Gluck O, et al. Clinical use of serum and urine bone markers in the management of osteoporosis. Curr Med Res Opin. 2005; 21:1015–26.SrivastavaAKVlietELMichaelLewiecki EMaricicMAbdelmalekAGluckOClinical use of serum and urine bone markers in the management of osteoporosisCurr Med Res Opin20052110152610.1185/030079905X4963516004668Search in Google Scholar

[3]Grey A, Bolland M, Wong S, Horne A, Gamble G, Reid IR. Low-dose zoledronate in osteopenic postmenopausal women: a randomized controlled trial. J Clin Endocr Metab. 2012; 97:286–92.GreyABollandMWongSHorneAGambleGReidIRLow-dose zoledronate in osteopenic postmenopausal women: a randomized controlled trialJ Clin Endocr Metab2012972869210.1097/OGX.0b013e3182583c55Search in Google Scholar

[4]Eastell R, Hannon RA. Biomarkers of bone health and osteoporosis risk: symposium on ‘diet and bone health’. Proc Nutr Soc. 2008; 67:157–62.EastellRHannonRABiomarkers of bone health and osteoporosis risk: symposium on ‘diet and bone health’Proc Nutr Soc2008671576210.1017/S002966510800699X18412989Search in Google Scholar

[5]Naylor K, Eastell R. Bone turnover markers: use in osteoporosis. Nat Rev Rheumatol. 2012; 8:379.NaylorKEastellRBone turnover markers: use in osteoporosisNat Rev Rheumatol2012837910.1038/nrrheum.2012.8622664836Search in Google Scholar

[6]Claudon A, Vergnaud P, Valverde C, Mayr A, Klause U, Garnero P. New automated multiplex assay for bone turnover markers in osteoporosis. Clin Chem. 2008; 54:1554–63.ClaudonAVergnaudPValverdeCMayrAKlauseUGarneroPNew automated multiplex assay for bone turnover markers in osteoporosisClin Chem20085415546310.1373/clinchem.2008.10586618676587Search in Google Scholar

[7]Ebeling PR, Åkesson K. Role of biochemical markers in the management of osteoporosis. Best Pract Res Clin Rheumatol. 2001; 15:385–400.EbelingPRÅkessonKRole of biochemical markers in the management of osteoporosisBest Pract Res Clin Rheumatol20011538540010.1053/berh.2001.015611485336Search in Google Scholar

[8]Donescu O, Battie M, Videman T, Risteli J, Eyre D. The predictive role of bone turnover markers for BMD in middle-aged men. Aging Male. 2006; 9:97–102.DonescuOBattieMVidemanTRisteliJEyreDThe predictive role of bone turnover markers for BMD in middle-aged menAging Male200699710210.1080/1368553060070863116916744Search in Google Scholar

[9]Yoshimura N, Muraki S, Oka H, Kawaguchi H, Nakamura K, Akune T. Biochemical markers of bone turnover as predictors of osteoporosis and osteoporotic fractures in men and women: 10-year follow-up of the Taiji cohort. Mod Rheumatol. 2011; 21:608–20.YoshimuraNMurakiSOkaHKawaguchiHNakamuraKAkuneTBiochemical markers of bone turnover as predictors of osteoporosis and osteoporotic fractures in men and women: 10-year follow-up of the Taiji cohortMod Rheumatol2011216082010.3109/s10165-011-0455-2Search in Google Scholar

[10]Kharroubi A, Saba E, Smoom R, Bader K, Darwish H. Serum 25-hydroxyvitamin D and bone turnover markers in Palestinian postmenopausal osteoporosis and normal women. Arch Osteoporos. 2017; 12:13.KharroubiASabaESmoomRBaderKDarwishHSerum 25-hydroxyvitamin D and bone turnover markers in Palestinian postmenopausal osteoporosis and normal womenArch Osteoporos2017121310.1007/s11657-017-0306-7526678328124221Search in Google Scholar

[11]Hlaing TT, Compston JE. Biochemical markers of bone turnover–uses and limitations. Ann Clin Biochem. 2014; 51:189–202.HlaingTTCompstonJEBiochemical markers of bone turnover–uses and limitationsAnn Clin Biochem20145118920210.1177/000456321351519024399365Search in Google Scholar

[12]Lumachi F, Ermani M, Camozzi V, Tombolan V, Luisetto G. Changes of bone formation markers osteocalcin and bone-specific alkaline phosphatase in postmenopausal women with osteoporosis. Ann N Y Acad Sci. 2009; 1173:E60–3.LumachiFErmaniMCamozziVTombolanVLuisettoGChanges of bone formation markers osteocalcin and bone-specific alkaline phosphatase in postmenopausal women with osteoporosisAnn N Y Acad Sci20091173E60310.1111/j.1749-6632.2009.04953.x19751416Search in Google Scholar

[13]Zhao D, Wang J, Liu Y, Liu X. Expressions and clinical significance of serum bone Gla-protein, bone alkaline phosphatase and C-terminal telopeptide of type I collagen in bone metabolism of patients with osteoporosis. Pak J Med Sci. 2015; 31:91.ZhaoDWangJLiuYLiuXExpressions and clinical significance of serum bone Gla-protein, bone alkaline phosphatase and C-terminal telopeptide of type I collagen in bone metabolism of patients with osteoporosisPak J Med Sci2015319110.12669/pjms.311.6143438616425878621Search in Google Scholar

[14]Li N, Zheng Y-B, Han J, Liang W, Wang J-Y, Zhou J-R, et al. Lower circulating preptin levels in male patients with osteoporosis are correlated with bone mineral density and bone formation. BMC Musculoskelet Dis. 2013; 14:49.LiNZhengY-BHanJLiangWWangJ-YZhouJ-RLower circulating preptin levels in male patients with osteoporosis are correlated with bone mineral density and bone formationBMC Musculoskelet Dis2013144910.1186/1471-2474-14-49357028823363476Search in Google Scholar

[15]Ohishi T, Fujita T, Nishida T, Asukai M, Suzuki D, Sugiura K, et al. Factors influencing serum homocysteine levels in postmenopausal osteoporotic females–comparison to urinary collagen crosslinks. Endocr Res. 2019; 44:117–25.OhishiTFujitaTNishidaTAsukaiMSuzukiDSugiuraKFactors influencing serum homocysteine levels in postmenopausal osteoporotic females–comparison to urinary collagen crosslinksEndocr Res2019441172510.1080/07435800.2019.157789230760054Search in Google Scholar

[16]Garnero P, Ferreras M, Karsdal M, Nicamhlaoibh R, Risteli J, Borel O, et al. The type I collagen fragments ICTP and CTX reveal distinct enzymatic pathways of bone collagen degradation. J Bone Miner Res. 2003; 18:859–67.GarneroPFerrerasMKarsdalMNicamhlaoibhRRisteliJBorelOThe type I collagen fragments ICTP and CTX reveal distinct enzymatic pathways of bone collagen degradationJ Bone Miner Res2003188596710.1359/jbmr.2003.18.5.85912733725Search in Google Scholar

[17]Mishra D, Sivaram Gopalakrishnan K, Kumar TSS, Devanathan S, Misra SR. Evaluation of salivary levels of pyridinoline cross linked carboxyterminal telopeptide of type I collagen (ICTP) in periodontal health and disease. J Clin Diagn Res. 2015; 9:ZC50.MishraDSivaramGopalakrishnan KKumarTSSDevanathanSMisraSREvaluation of salivary levels of pyridinoline cross linked carboxyterminal telopeptide of type I collagen (ICTP) in periodontal health and diseaseJ Clin Diagn Res20159ZC5010.7860/JCDR/2015/12689.6498460634226501013Search in Google Scholar

[18]Seifert-Klauss V, Prior JC. Progesterone and bone: actions promoting bone health in women. J Osteoporosis. 2010; 2010:845180.Seifert-KlaussVPriorJCProgesterone and bone: actions promoting bone health in womenJ Osteoporosis2010201084518010.4061/2010/845180296841621052538Search in Google Scholar

[19]Cauley JA. Estrogen and bone health in men and women. Steroids. 2015; 99:11–5.CauleyJAEstrogen and bone health in men and womenSteroids20159911510.1016/j.steroids.2014.12.01025555470Search in Google Scholar

[20]von Mach-Szczypiński J, Stanosz S, Kościuszkiewicz J, Safranow K. New aspects of postmenopausal osteoporosis treatment with micronized estradiol and progesterone. Ginekol Pol. 2016; 87:739–44.vonMach-Szczypiński JStanoszSKościuszkiewiczJSafranowKNew aspects of postmenopausal osteoporosis treatment with micronized estradiol and progesteroneGinekol Pol2016877394410.5603/GP.2016.008027958631Search in Google Scholar

[21]Khosla S, Oursler MJ, Monroe DG. Estrogen and the skeleton. Trends Endocrinol Metabol. 2012; 23:576–81.KhoslaSOurslerMJMonroeDGEstrogen and the skeletonTrends Endocrinol Metabol2012235768110.1016/j.tem.2012.03.008342438522595550Search in Google Scholar

[22]Yoldemir T, Erenus M, Durmusoglu F. The impact of serum FSH and estradiol on postmenopausal osteoporosis related to time since menopause. Gynecol Endocrinol. 2012; 28:884–8.YoldemirTErenusMDurmusogluFThe impact of serum FSH and estradiol on postmenopausal osteoporosis related to time since menopauseGynecol Endocrinol201228884810.3109/09513590.2012.68306622731753Search in Google Scholar

[23]Nguyen HT, von Schoultz B, Nguyen TV, Thang TX, Chau TT, Duc PT, et al. Sex hormone levels as determinants of bone mineral density and osteoporosis in Vietnamese women and men. J Bone Miner Metab. 2015; 33:658–65.NguyenHTvonSchoultz BNguyenTVThangTXChauTTDucPTSex hormone levels as determinants of bone mineral density and osteoporosis in Vietnamese women and menJ Bone Miner Metab2015336586510.1007/s00774-014-0629-z25300746Search in Google Scholar

[24]Hosseini SR, Cumming RG, Kheirkhah F, Nooreddini H, Baiani M, Mikaniki E, et al. Cohort profile: the Amirkola health and ageing project (AHAP). Int J Epidemiol. 2014; 43:1393–400.HosseiniSRCummingRGKheirkhahFNooreddiniHBaianiMMikanikiECohort profile: the Amirkola health and ageing project (AHAP)Int J Epidemiol201443139340010.1093/ije/dyt08923918798Search in Google Scholar

[25]Moemeni H, Moallem M, Parsian H, Hosseini SR, Noreddini H, Mosapour A, et al. A comparison of serum lead status among elderly osteopaenic patients, elderly osteoporotic patients and healthy controls. W Indian Med J. 2015; 67:248–53.MoemeniHMoallemMParsianHHosseiniSRNoreddiniHMosapourAA comparison of serum lead status among elderly osteopaenic patients, elderly osteoporotic patients and healthy controlsW Indian Med J2015672485310.7727/wimj.2015.103Search in Google Scholar

[26]Pilatti FK, Ramlov F, Schmidt EC, Costa C, Oliveira ER, Bauer CM, et al. Metabolomics of Ulva lactuca Linnaeus (Chlorophyta) exposed to oil fuels: Fourier transform infrared spectroscopy and multivariate analysis as tools for metabolic fingerprint. Mar Pollut Bull. 2017; 114:831–6.PilattiFKRamlovFSchmidtECCostaCOliveiraERBauerCMMetabolomics of Ulva lactuca Linnaeus (Chlorophyta) exposed to oil fuels: Fourier transform infrared spectroscopy and multivariate analysis as tools for metabolic fingerprintMar Pollut Bull2017114831610.1016/j.marpolbul.2016.11.00627847170Search in Google Scholar

[27]Hosseini SR, Cumming RG, Kheirkhah F, Nooreddini H, Baiani M, Mikaniki E, et al. Cohort profile: the Amirkola health and ageing project (AHAP). Int J Epidemiol. 2013; 43:1393–400.HosseiniSRCummingRGKheirkhahFNooreddiniHBaianiMMikanikiECohort profile: the Amirkola health and ageing project (AHAP)Int J Epidemiol201343139340010.1093/ije/dyt089Search in Google Scholar

[28]Moallem M, Parsian H, Mosapour A, Hosseini SR, Nooreddini H, Shirhanik Z, et al. Predicting osteopenia and osteoporosis with a simple test: a preliminary work. W Indian Med J. 2015; 65:158–64.MoallemMParsianHMosapourAHosseiniSRNooreddiniHShirhanikZPredicting osteopenia and osteoporosis with a simple test: a preliminary workW Indian Med J2015651586410.7727/wimj.2014.253Search in Google Scholar

[29]Tehrani SS, Sarfi M, Yousefi T, Ahangar AA, Gholinia H, Ahangar RM, et al. Comparison of the calcium-related factors in Parkinson's disease patients with healthy individuals. Caspian J Intern Med. 2020; 11:28.TehraniSSSarfiMYousefiTAhangarAAGholiniaHAhangarRMComparison of the calcium-related factors in Parkinson's disease patients with healthy individualsCaspian J Intern Med20201128Search in Google Scholar

[30]Lumachi F, Ermani M, Camozzi V, Tombolan V, Luisetto G. Changes of bone formation markers osteocalcin and bone-specific alkaline phosphatase in postmenopausal women with osteoporosis. Ann N Y Acad Sci. 2009; 1173(Suppl 1):E60–3.LumachiFErmaniMCamozziVTombolanVLuisettoGChanges of bone formation markers osteocalcin and bone-specific alkaline phosphatase in postmenopausal women with osteoporosisAnn N Y Acad Sci20091173Suppl 1E60310.1111/j.1749-6632.2009.04953.x19751416Search in Google Scholar

[31]Lormeau C, Soudan B, d’Herbomez M, Pigny P, Duquesnoy B, Cortet B. Sex hormone-binding globulin, estradiol, and bone turnover markers in male osteoporosis. Bone. 2004; 34:933–9.LormeauCSoudanBd’HerbomezMPignyPDuquesnoyBCortetBSex hormone-binding globulin, estradiol, and bone turnover markers in male osteoporosisBone200434933910.1016/j.bone.2004.01.02415193539Search in Google Scholar

[32]Lee J, Vasikaran S. Current recommendations for laboratory testing and use of bone turnover markers in management of osteoporosis. Ann Lab Med. 2012; 32:105–12.LeeJVasikaranSCurrent recommendations for laboratory testing and use of bone turnover markers in management of osteoporosisAnn Lab Med2012321051210.3343/alm.2012.32.2.105328977422389876Search in Google Scholar

[33]Krege JH, Lane NE, Harris JM, Miller PD. PINP as a biological response marker during teriparatide treatment for osteoporosis. Osteoporos Int. 2014; 25:2159–71.KregeJHLaneNEHarrisJMMillerPDPINP as a biological response marker during teriparatide treatment for osteoporosisOsteoporos Int20142521597110.1007/s00198-014-2646-0413448524599274Search in Google Scholar

[34]Meier C, Nguyen TV, Center JR, Seibel MJ, Eisman JA. Bone resorption and osteoporotic fractures in elderly men: the dubbo osteoporosis epidemiology study. J Bone Miner Res. 2005; 20:579–87.MeierCNguyenTVCenterJRSeibelMJEismanJABone resorption and osteoporotic fractures in elderly men: the dubbo osteoporosis epidemiology studyJ Bone Miner Res2005205798710.1359/JBMR.041207Search in Google Scholar

[35]Clemens JD, Herrick MV, Singer FR, Eyre DR. Evidence that serum NTx (collagen-type I N-telopeptides) can act as an immuno-chemical marker of bone resorption. Clin Chem. 1997; 43:2058–63.ClemensJDHerrickMVSingerFREyreDREvidence that serum NTx (collagen-type I N-telopeptides) can act as an immuno-chemical marker of bone resorptionClin Chem19974320586310.1093/clinchem/43.11.2058Search in Google Scholar

[36]Woitge HW, Pecherstorfer M, Li Y, Keck AV, Horn E, Ziegler R, et al. Novel serum markers of bone resorption: clinical assessment and comparison with established urinary indices. J Bone Miner Res. 1999; 14:792–801.WoitgeHWPecherstorferMLiYKeckAVHornEZieglerRNovel serum markers of bone resorption: clinical assessment and comparison with established urinary indicesJ Bone Miner Res19991479280110.1359/jbmr.1999.14.5.792Search in Google Scholar

[37]de la Piedra C, Traba ML, Cabrera CD, Henríquez MS. New biochemical markers of bone resorption in the study of postmenopausal osteoporosis. Clin Chim Acta. 1997; 265:225–34.dela Piedra CTrabaMLCabreraCDHenríquezMSNew biochemical markers of bone resorption in the study of postmenopausal osteoporosisClin Chim Acta19972652253410.1016/S0009-8981(97)00131-9Search in Google Scholar

[38]Schneider DL, Barrett-Connor EL. Urinary N-telopeptide levels discriminate normal, osteopenic, and osteoporotic bone mineral density. Arch Intern Med. 1997; 157:1241–5.SchneiderDLBarrett-ConnorELUrinary N-telopeptide levels discriminate normal, osteopenic, and osteoporotic bone mineral densityArch Intern Med19971571241510.1001/archinte.1997.00440320149014Search in Google Scholar

[39]Scariano J, Glew R, Bou-Serhal C, Clemens J, Garry P, Baumgartner R. Serum levels of cross-linked N-telopeptides and aminoterminal propeptides of type I collagen indicate low bone mineral density in elderly women. Bone. 1998; 23:471–7.ScarianoJGlewRBou-SerhalCClemensJGarryPBaumgartnerRSerum levels of cross-linked N-telopeptides and aminoterminal propeptides of type I collagen indicate low bone mineral density in elderly womenBone199823471710.1016/S8756-3282(98)00126-4Search in Google Scholar

[40]Swanson CM, Kohrt WM, Buxton OM, Everson CA, Wright KP Jr, Orwoll ES, et al. The importance of the circadian system and sleep for bone health. Metabolism. 2018; 84:28–43.SwansonCMKohrtWMBuxtonOMEversonCAWrightKP JrOrwollESThe importance of the circadian system and sleep for bone healthMetabolism201884284310.1016/j.metabol.2017.12.002599417629229227Search in Google Scholar

[41]Feskanich D, Hankinson SE, Schernhammer ES. Nightshift work and fracture risk: the Nurses’ Health Study. Osteoporos Int. 2009; 20:537–42.FeskanichDHankinsonSESchernhammerESNightshift work and fracture risk: the Nurses’ Health StudyOsteoporos Int2009205374210.1007/s00198-008-0729-5265199818766292Search in Google Scholar

[42]Kohrt WM, Bloomfield SA, Little KD, Nelson ME, Yingling VR. Physical activity and bone health. Med Sci Sports Exerc. 2004; 36:1985–96.KohrtWMBloomfieldSALittleKDNelsonMEYinglingVRPhysical activity and bone healthMed Sci Sports Exerc20043619859610.1249/01.MSS.0000142662.21767.58Search in Google Scholar

[43]Rexhepi S, Bahtiri E, Rexhepi M, Sahatciu-Meka V, Rexhepi B. Association of body weight and body mass index with bone mineral density in women and men from Kosovo. Materia Socio-Medica. 2015; 27:259.RexhepiSBahtiriERexhepiMSahatciu-MekaVRexhepiBAssociation of body weight and body mass index with bone mineral density in women and men from KosovoMateria Socio-Medica20152725910.5455/msm.2015.27.259-262461060626543419Search in Google Scholar

[44]Lei S-F, Deng F-Y, Li M-X, Dvornyk V, Deng H-W. Bone mineral density in elderly Chinese: effects of age, sex, weight, height, and body mass index. J Bone Miner Metab. 2004; 22:71–8.LeiS-FDengF-YLiM-XDvornykVDengH-WBone mineral density in elderly Chinese: effects of age, sex, weight, height, and body mass indexJ Bone Miner Metab20042271810.1007/s00774-003-0452-414691691Search in Google Scholar

[45]Chaudhary NK, Timilsena MN, Sunuwar DR, Pradhan PMS, Sangroula RK. Association of lifestyle and food consumption with bone mineral density among people aged 50 years and above attending the hospitals of Kathmandu, Nepal. J Osteoporos. 2019; 2019:1536394.ChaudharyNKTimilsenaMNSunuwarDRPradhanPMSSangroulaRKAssociation of lifestyle and food consumption with bone mineral density among people aged 50 years and above attending the hospitals of Kathmandu, NepalJ Osteoporos20192019153639410.1155/2019/1536394655626431240093Search in Google Scholar

[46]Baldock PA, Thomas GP, Hodge JM, Baker SU, Dressel U, O’Loughlin PD, et al. Vitamin D action and regulation of bone remodeling: suppression of osteoclastogenesis by the mature osteoblast. J Bone Miner Res. 2006; 21:1618–26.BaldockPAThomasGPHodgeJMBakerSUDresselUO’LoughlinPDVitamin D action and regulation of bone remodeling: suppression of osteoclastogenesis by the mature osteoblastJ Bone Miner Res20062116182610.1359/jbmr.06071416995817Search in Google Scholar

[47]Rowe P, Koller A, Sharma S. Physiology, bone remodeling. StatPearls. Florida: StatPearls Publishing, 2020.RowePKollerASharmaSPhysiology, bone remodelingStatPearlsFloridaStatPearls Publishing2020Search in Google Scholar

[48]Holmberg T, Bech M, Curtis T, Juel K, Grønbæk M, Brixen K. Association between passive smoking in adulthood and phalangeal bone mineral density: results from the KRAM study—the Danish Health Examination Survey 2007–2008. Osteoporos Int. 2011; 22:2989–99.HolmbergTBechMCurtisTJuelKGrønbækMBrixenKAssociation between passive smoking in adulthood and phalangeal bone mineral density: results from the KRAM study—the Danish Health Examination Survey 2007–2008Osteoporos Int20112229899910.1007/s00198-010-1506-921170642Search in Google Scholar

[49]Lee JJ, Patel R, Biermann JS, Dougherty PJ. The musculoskeletal effects of cigarette smoking. J Bone Joint Surg Am. 2013; 95:850–9.LeeJJPatelRBiermannJSDoughertyPJThe musculoskeletal effects of cigarette smokingJ Bone Joint Surg Am201395850910.2106/JBJS.L.0037523636193Search in Google Scholar

[50]Berg KM, Kunins HV, Jackson JL, Nahvi S, Chaudhry A, Harris KA Jr, et al. Association between alcohol consumption and both osteoporotic fracture and bone density. Am J Med. 2008; 121:406–18.BergKMKuninsHVJacksonJLNahviSChaudhryAHarrisKA JrAssociation between alcohol consumption and both osteoporotic fracture and bone densityAm J Med20081214061810.1016/j.amjmed.2007.12.012269236818456037Search in Google Scholar

[51]Digitale E, Hathaway C, Heneman K, Zidenberg-Cherr S. Nutrition and health info sheet. Calcium and Osteoporosis. 2008. (2008). Nutrition and Health Info Sheet: Calcium. http://dx.doi.org/10.3733/ucanr.8143. Available from: https://escholarship.org/uc/item/5mk6s5t4DigitaleEHathawayCHenemanKZidenberg-CherrSNutrition and health info sheetCalcium and Osteoporosis20082008Nutrition and Health Info Sheet: Calcium. http://dx.doi.org/10.3733/ucanr.8143. Available from: https://escholarship.org/uc/item/5mk6s5t410.3733/ucanr.8143Search in Google Scholar

[52]Nordström A, Tervo T, Högström M. The effect of physical activity on bone accrual, osteoporosis and fracture prevention. Open Bone J. 2011; 3:11–21.NordströmATervoTHögströmMThe effect of physical activity on bone accrual, osteoporosis and fracture preventionOpen Bone J20113112110.2174/1876525401103010011Search in Google Scholar

[53]Chubak J, Ulrich CM, Tworoger SS, Sorensen B, Yasui Y, Irwin ML, et al. Effect of exercise on bone mineral density and lean mass in postmenopausal women. Med Sci Sports Exerc. 2006; 38:1236–44.ChubakJUlrichCMTworogerSSSorensenBYasuiYIrwinMLEffect of exercise on bone mineral density and lean mass in postmenopausal womenMed Sci Sports Exerc20063812364410.1249/01.mss.0000227308.11278.d716826020Search in Google Scholar

[54]Khosla S, Melton LJ III, Riggs BL. The unitary model for estrogen deficiency and the pathogenesis of osteoporosis: is a revision needed? J Bone Miner Res. 2011; 26:441–51.KhoslaSMeltonLJ IIIRiggsBLThe unitary model for estrogen deficiency and the pathogenesis of osteoporosis: is a revision needed?J Bone Miner Res2011264415110.1002/jbmr.262317929820928874Search in Google Scholar

[55]Ji M-X, Yu Q. Primary osteoporosis in postmenopausal women. Chronic Dis Transl Med.. 2015; 1:9–13.JiM-XYuQPrimary osteoporosis in postmenopausal womenChronic Dis Transl Med2015191310.1016/j.cdtm.2015.02.006Search in Google Scholar

[56]Clapauch R, Mattos TM, Silva P, Marinheiro LP, Buksman S, Schrank Y. Total estradiol, rather than testosterone levels, predicts osteoporosis in aging men. Arq Bras Endocrinol Metabol. 2009; 53:1020–5.ClapauchRMattosTMSilvaPMarinheiroLPBuksmanSSchrankYTotal estradiol, rather than testosterone levels, predicts osteoporosis in aging menArq Bras Endocrinol Metabol2009531020510.1590/S0004-2730200900080001720126856Search in Google Scholar

[57]Gillberg P, Johansson AG, Ljunghall S. Decreased estradiol levels and free androgen index and elevated sex hormone-binding globulin levels in male idiopathic osteoporosis. Calcif Tissue Int. 1999; 64:209–13.GillbergPJohanssonAGLjunghallSDecreased estradiol levels and free androgen index and elevated sex hormone-binding globulin levels in male idiopathic osteoporosisCalcif Tissue Int1999642091310.1007/s00223990060410024377Search in Google Scholar

[58]Lu L-JW, Nayeem F, Anderson KE, Grady JJ, Nagamani M. Lean body mass, not estrogen or progesterone, predicts peak bone mineral density in premenopausal women. J Nutr. 2009; 139:250–6.LuL-JWNayeemFAndersonKEGradyJJNagamaniMLean body mass, not estrogen or progesterone, predicts peak bone mineral density in premenopausal womenJ Nutr2009139250610.3945/jn.108.098954263552519106315Search in Google Scholar

[59]Cabrera CD, Henríquez MS, Traba M, Villafañe EA, De la Piedra C. Biochemical markers of bone formation in the study of postmenopausal osteoporosis. Osteoporos Int. 1998; 8:147–51.CabreraCDHenríquezMSTrabaMVillafañeEADe la PiedraCBiochemical markers of bone formation in the study of postmenopausal osteoporosisOsteoporos Int199881475110.1007/BF026725119666938Search in Google Scholar

[60]Yılmaz N, Bayram M, Erbağcý AB, Kýlýnçer MŞ. Diagnostic value of biochemical markers of bone turnover and postmenopausal osteoporosis. Clin Chem Lab Med. 1999; 37:137–43.YılmazNBayramMErbağcýABKýlýnçerMŞDiagnostic value of biochemical markers of bone turnover and postmenopausal osteoporosisClin Chem Lab Med1999371374310.1515/CCLM.1999.02510219502Search in Google Scholar